AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

NCT05522894 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Esophageal Squamous Cell Carcinoma
Locally Advanced Esophageal Squamous Cell Carcinoma
Metastatic Esophageal Squamous Cell Carcinoma

Interventions

DRUG: AK104
DRUG: Cisplatin
DRUG: Paclitaxel

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]